A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

October 10, 2023 updated by: Zimmer Biomet
The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.

Study Overview

Detailed Description

The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System in both primary and revision procedures, report safety and survivorship, and document instrument ease of use.

Study Type

Observational

Enrollment (Estimated)

315

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • Clermont-Ferrand Hospital
      • Würzburg, Germany
        • University of Würzburg, Orthopedic
      • Limerick, Ireland
        • Midwestern Regional Orthopaedic Hospital
      • Delft, Netherlands
        • Reinier de Graaf Groep
      • Ponferrada, Spain
        • Hospital El Bierzo
    • Arizona
      • Tucson, Arizona, United States, 85718
        • University Orthopedic Specialists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Primary care clinic

Description

Inclusion Criteria:

  • Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid arthritis
  • Correction of functional deformity
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
  • Revision procedures where other treatment or devices have failed
  • 18 years of age or older
  • Subjects willing to return for follow-up evaluations

Exclusion Criteria:

  • Infection, sepsis and osteomyelitis
  • Subjects unable to cooperate with and complete the study
  • Neurological conditions affecting movement
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Metal on Polyethylene articulation
G7 cup with Metal on Polyethylene articulation (MOP)
G7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)
Other Names:
  • MOP
Ceramic on Polyethylene articulation
G7 cup with Ceramic on Polyethylene articulation (COP)
G7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)
Other Names:
  • COP
Ceramic on Ceramic articulation
G7 cup with Ceramic on Ceramic articulation (COC)
G7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY
Other Names:
  • COC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Hip Score
Time Frame: 2 Year post-operative

The Harris Hip Scale (HHS) was developed to assess the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in adults. The original version was published 1969. The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist.

The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.

2 Year post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxford Hip Score
Time Frame: 1 Year post-operative
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.
1 Year post-operative
Oxford Hip Score
Time Frame: 2 Year post-operative
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.
2 Year post-operative
Oxford Hip Score
Time Frame: 5 Year post-operative
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.
5 Year post-operative
Radiographic Evaluation
Time Frame: 1 Year post-operative

Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.

The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line.

1 Year post-operative
Radiographic Evaluation
Time Frame: 2 Year post-operative

Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.

The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line.

2 Year post-operative
Radiographic Evaluation
Time Frame: 5 Year post-operative

Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.

The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line.

5 Year post-operative
Survivorship
Time Frame: 7 Year post-operative
Questionnaire
7 Year post-operative
Survivorship
Time Frame: 10 Year post-operative
Questionnaire
10 Year post-operative
Adverse Events
Time Frame: Up to 10 years postoperatively
Adverse events will be documented according to ISO 14155:2011 definitions previously described. For the purposes of this study, only adverse events meeting SAE, ADE, SADE, and USADE criteria will be included, unless otherwise reported at the discretion of the investigator.
Up to 10 years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Hassan Achakri, PhD, Zimmer Biomet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2013

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

January 14, 2014

First Submitted That Met QC Criteria

January 14, 2014

First Posted (Estimated)

January 15, 2014

Study Record Updates

Last Update Posted (Actual)

October 11, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ORTHO.CR.GH20.13

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Metal on Polyethylene articulation

3
Subscribe